We then established the cross-reactivity of OC43-elicited T cells to SARS-CoV-2 peptides, examined the effect of prior exposure to OC43 on subsequent SARS-CoV-2 infection and lung disease, and determined the contribution of cross-reactive CD4+ T cells to OC43-induced cross-protection. The gene discussed is CD4; the disease is lung disorder.